The Effect of the Egg Shell Nanoparticles Combined With Titanium Dioxide Nanoparticles

Sponsor
Egymedicalpedia (Industry)
Overall Status
Completed
CT.gov ID
NCT06025084
Collaborator
(none)
24
1
2
3.9
6.1

Study Details

Study Description

Brief Summary

Dentin hypersensitivity is one of the most commonly occurring clinical dental conditions which is characterized by short and sharp pain which arises from exposed dentin in response to external stimuli, which typically are thermal, evaporative, tactile, osmotic or chemical.

Hypersensitive dentin is mostly found in buccal tooth areas, in which enamel is missing because of abrasion, attrition, or erosion. The most generally accepted theory regarding the mechanism of dentin hypersensitivity is the hydrodynamic theory. It proposes that a pain-provoking stimulus increases the flow of the dentinal tubular fluid and consequently, stimulates the nerves around the odontoblasts, leading to dentin hypersensitivity.

Condition or Disease Intervention/Treatment Phase
  • Drug: Egg Shell nanoparticles
Phase 1

Detailed Description

Dentin desensitizing products, containing agents such as fluoride, strontium salts, oxalate, glutaraldehyde and bioactive glass, are employed to treat dentin hypersensitivity.

Based on the hydrodynamic theory, there are two main strategies for the treatment of dentin hypersensitivity as: (1) occluding the dentinal tubules to reduce the fluid flow, and (2) decreasing the excitability of the intradental nerve.

Although these products and agents were reported to be effective, short durability and poor effectiveness were often exhibited. The therapeutic effects of these desensitizing products were short lived on account of daily tooth brushing or drinking of acidic beverages and the occlusion effects were sometimes incomplete. Owing to these drawbacks, the use of nanomaterials as dentin occluding material has been predicted to be the future of treating DH.

Amorphous Calcium Phosphate (ACP) has the potential to remineralize the structure of tooth. ACP is a soluble calcium phosphate compound that discharges calcium and phosphate ions to change to apatite and remineralize the tooth structure when it comes in contact with saliva. Forming on the enamel and within the dental tubules, ACP provides a reservoir of phosphate and calcium ions in the saliva Casein phospho-peptide (CPP) is a milk-derived protein that joins to the tooth's biofilm and is applied to stabilize ACP. In recent years, remineralization products used CPP as a vehicle to deliver and preserve a super saturation state of ACP near the surface of tooth. A previous study showed that the application of (CPP-ACP) containing agents as GC tooth mousse and MI paste plus can reduce dentin permeability by occluding dentin tubules. It revealed that these materials can be effective for treatment of dentin hypersensitivity.

Recently, there has been a renewed interest in developing materials with a bioactive potential that could block the exposed dentinal tubules and subsequently reduce the fluid flow within the tubules. Eggshells (EBs) have been investigated in recent years for their remineralization capabilities. EB has rich bioavailable calcium content in the form of carbonates and oxides. It contains 94% calcium carbonate, 1% calcium phosphate, 1% magnesium carbonate, and 4% organic matter. In addition, eggshell provides a cost-effective, renewable, and sustainable source of material for EnHAp. A previous study revealed that eggshell powder is predicted to be the future of tooth remineralization and highly effective in occluding dentinal tubules and reducing dentin hypersensitivity.

Titanium dioxide is one of the few materials that classified as bioactive meaning that it enhances bone growth and stable bone bonding with dental implants via precipitation of hydroxyapatite on its surface

Study Design

Study Type:
Interventional
Actual Enrollment :
24 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
The Effect of Egg Shell Nanoparticles Combined With Titanium Dioxide Nanoparticles on The Permeability of Dentinal Tubules After Exposure to Wear Challenges and Their Clinical Efficacy in The Treatment of Dentin Hypersensitivity
Actual Study Start Date :
Dec 1, 2022
Actual Primary Completion Date :
Mar 15, 2023
Actual Study Completion Date :
Mar 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: first group (A1)

About 24 patients hypersensitive teeth. So the hypersensitive teeth will be treated with egg shell nanoparticles

Drug: Egg Shell nanoparticles
Evaluate the effects of egg shell nanoparticles combined with Titanium dioxide nanoparticles in the treatment of dentin hypersensitivity at different time intervals.
Other Names:
  • Titanium dioxide nanoparticles
  • Active Comparator: second group (A2)

    About 24 patients hypersensitive teeth. treated with the combination therapy of eggshell and TiO2.

    Drug: Egg Shell nanoparticles
    Evaluate the effects of egg shell nanoparticles combined with Titanium dioxide nanoparticles in the treatment of dentin hypersensitivity at different time intervals.
    Other Names:
  • Titanium dioxide nanoparticles
  • Outcome Measures

    Primary Outcome Measures

    1. Assessment of dentin hypersensitivity [from baseline to 2 months after the treatment day.]

      The pain response will be assessed using the numerical Visual Analogue Scale (VAS, range 0-10), with 0 indicating 'no pain' and 10 indicating 'intolerably severe pain.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years to 55 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    1- For patients;

    • Age between 20 and 55 years

    • Patients in good systemic health with clinically elicitable dentin hypersensitivity

    • Absence of contraindications to the proposed therapies as allergy. 2 - For teeth;

    • Absence of local pathologies (e.g., caries and fractures)

    • Visual analog scale (VAS) score ≥3

    Exclusion Criteria:
    • -- For patients;

    • Use of any desensitizing toothpaste for previous 3 or 4 months.

    • Taking analgesics/anti-inflammatory drugs at the time of the study, pregnancy, and smoking.

    2 -For teeth ;

    • Teeth with abrasion and attrition.

    • Carious lesions on the selected or neighboring teeth, defective restorations

    • Any professional desensitizing therapy on the selected teeth during the last 6 months.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Faculty of Dentistary - Al-Azhar University Cairo Egypt

    Sponsors and Collaborators

    • Egymedicalpedia

    Investigators

    • Principal Investigator: Fatma Hussein, Lecturer, Al-Azhar Faculty of Dentistary for girls

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Egymedicalpedia
    ClinicalTrials.gov Identifier:
    NCT06025084
    Other Study ID Numbers:
    • Fadia Ali El-Sayed Shosha
    First Posted:
    Sep 6, 2023
    Last Update Posted:
    Sep 6, 2023
    Last Verified:
    Aug 1, 2023
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 6, 2023